iData provides one of the most comprehensive and efficient market research survey services in the world using a 5-step methodology. Whether it is to gauge end-user behavior regarding new or existing products, competitor’s products, purchasing habits, marketing penetration/effectiveness rates, ad testing or obtaining statistically significant quantitative data on specific products and services, iData’s survey team is equipped and ready to engage.

The full report suite on the European market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), dialysis catheters, manufactured catheter securement devices (MCSDs) and syringes and needles. Vascular access devices are used for gaining access to a patient’s bloodstream via the veins. They can deliver a wide range of treatments, including fluid infusion, blood draws, parenteral nutrition, antibiotics, chemotherapy and dialysis. The duration of treatment lasts anywhere from hours to years, depending on the type of vascular access device used and the type of medication that is being infused.

Chronic total occlusions (CTOs) are complete blockages of arteries. In the case of a hard plaque, over 50% of the occlusion could consist of calcified tissue. Soft plaques typically consist of cholesterol, macrophages and other cells.
The most common method to cross a CTO is to attempt to pass a guidewire through. In other cases, a specialty hydrophilic guidewire may be used. However, if these guidewire-based methods are not sufficient due to poor visualization and calcified heterogeneous lesions, specialized devices must come into play to enable the subsequent deployment of a stent, PTA balloon or even most atherectomy devices.

Pulmonary embolism is a condition that affects over one million individuals each year in Europe and leads to mortality in almost a third of those afflicted. This condition is caused by the accumulation of dislodged bodies in the lungs. These usually originate from blood clots or thrombi from a deep vein in the leg.

Percutaneous transluminal angioplasty (PTA) balloon catheters can be used in two ways for the treatment of peripheral vascular lesions. One way is to expand the lumen of an obstructed blood vessel; this method is informally referred to as “plain old balloon angioplasty” (POBA). During POBA, the balloon catheter is inserted into the narrowed vascular region and expanded with water pressure to press the fatty deposits against the vessel walls.

Transcatheter embolization is the practice of introducing material to within the vasculature to induce blood flow occlusions. Transcatheter embolization is effective for treating vessel malformations such as aneurysms, fistulae and bleeding. If left untreated, some of these arteriovenous malformations can ultimately lead to strokes. In addition, transcatheter embolization is an effective therapy for blocking blood flow to tumors or organs, thus starving the target tissues. Specialized particles, such as drug-coated and radiolabeled beads, are used for the targeted delivery of drugs and for radiation therapy, respectively.

The full report suite on the European market for Peripheral Vascular (PV) devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent-grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices.

The U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often, a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation if left untreated.

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices, stent grafts, surgical grafts, inferior vena cava filters,
diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or
peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As a result of the
general increase in peripheral procedures and their relatively low cost, the market for PTA balloons is expected to grow rapidly in India over the forecast period.

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, embolic protection devices, stent grafts, surgical grafts, IVUS catheters, inferior vena cava filters, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As a result of the general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as atherectomy devices is expected to grow rapidly in Japan over the 2011–2018 forecast period.

The full report suite on the global market for cardiac leads includes cardiac leads, pacing leads, defibrillation leads and left ventricle (LV) leads.

The electrophysiology and ablation device market includes external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices.

The electrophysiology and ablation device market includes external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices.